Increased urine albumin excretion is associated with an unfavourable cardiovascular risk profile and prognosis in primary hypertension, even though its pathogenesis is currently unknown. Microalbuminuria (Mi) has been proposed as an integrated marker to identify patients with subclinical organ damage, but its routine use is still too often neglected in clinical practice. The aim of our study was to evaluate the relationship between urinary albumin excretion and early signs of subclinical target organ damage (TOD), namely left ventricular hypertrophy and carotid atherosclerosis in a large group of non diabetic hypertensive patients. A group of 346 never treated patients with primary hypertension (212 men, 134 women, mean age 47 ± 9 years) referred to our clinic were included in the study. They underwent the following procedures: (1) family and personal medical history and physical examination; (2) clinical blood pressure measurement; (3) routine blood chemistry and urine analysis including determination of urinary albumin excretion (ACR); (4) electrocardiogram; (5) ultrasound evaluation of left ventricular mass (LVMI) and
Introduction
Assessment of subclinical end-organ damage is a key element in the evaluation of patients with primary hypertension. In fact, detecting left ventricular hypertrophy (LVH) or peripheral atherosclerosis markedly increases the overall cardiovascular risk profile and may be helpful both for deciding whether to begin treatment and for identifying optimal target blood pressure. Microalbuminuria (Mi) has been associated with a number of unfavourable biohumoral risk factors as well as with subclinical organ damage in nondiabetic patients with primary hypertension. 3, 4 Recently, it was proven to be a predictor of cardiovascular morbidity and mortality in long term longitudinal studies. 5, 6 Even though the pathogenesis of increased urinary albumin excretion (UAE) is at present still unclear, this abnormality has been proposed as a useful integrated marker of target organ damage (TOD) and increased cardiovascular risk. 7 However, routine evaluation of Mi is not recommended by international guidelines as part of the diagnostic work-up of every hypertensive patient and its potential diagnostic power has not yet been fully exploited in clinical practice.
The aim of the present study was to evaluate the relationship between UAE and other signs of TOD, namely LVH and carotid atherosclerosis in a large group of untreated hypertensive patients. We tested the hypothesis that microalbuminuria is associated with the presence of target organ damage and therefore may be helpful in identifying the subgroup of hypertensive patients at higher cardiovascular risk.
Patients and methods

Patients and design
From January 1996 to January 1999 all previously untreated patients with primary hypertension attending the out-patient hypertension clinic of the Nephrology Unit at the Department of Internal Medicine (University of Genoa, Italy) were asked to participate in this study which was part of a larger clinical trial approved by the Ethical Committee of our Institution. Altogether 518 hypertensive patients were seen at our clinic within that period of time. The selection criteria for the study led to the exclusion of 125 patients as follows: diabetes mellitus (32 patients), severe obesity (defined as body weight Ͼ150% of ideal body weight) (22 patients), renal disease (21 patients), chronic heart failure (NYHA class III and IV) (17 patients), neoplastic disease (seven patients), hepatic disease (10 patients), positive history or clinical signs of ischaemic heart disease (14 patients), disabling diseases such as dementia or inability to cooperate (two patients). Hypertension was defined according to the criteria in the fifth report of the Joint National Committee (JNC V) as an average blood pressure of 140/90 mm Hg on at least two different occasions. Of the remaining 393 patients eligible to participate in the study on the basis of available clinical and laboratory data, 15 refused and 32 did not meet study criteria based on the results of additional tests prescribed for clinical reasons during their first examination. Data obtained from the remaining 346 patients (all Caucasian Europeans) form the basis of the present report. Of the participating patients, 246 (71%) had never been treated for hypertension, while 100 (29%) had received antihypertensive treatment in the past, albeit intermittently and not during the 6 months prior to the study.
After informed consent had been obtained, all patients were subjected to the following procedures within 2 weeks of the initial visit: (1) clinic blood pressure measurement, (2) blood and urine sampling for routine blood chemistry and urine examination, (3) evaluation of UAE, (4) standard 12-lead electrocardiogram (ECG), (5) echocardiogram, and (6) carotid ultrasonogram. On the study day, height and weight were measured, then venous blood was drawn after an overnight fast in order to measure haematochemical parameters. Blood pressure was measured by a trained nurse, with the patient in a sitting position after a 5-min rest, with a mercury sphygmomanometer (cuff size 12.5 × 40 cm). The systolic and diastolic blood pressures were read to the nearest 2 mm Hg. Disappearance of Korotkoff's sounds (phase V) was the criterion for diastolic blood pressure. The lowest of three consecutive readings was recorded. Body mass index (BMI) was calculated by the formula: BMI = weight (kg)/height (m 2 ). Low-density cholesterol (LDL)-cholesterol was calculated using Friedewald's formula. 8 Creatinine clearance was calculated using Cockcroft-Gault's formula 9 and is expressed in ml/min. Family history and lifestyle habits were assessed by means of a standard questionnaire. Smoking was graded using a three-point scale: non-smoker, ex-smoker, and active smoker.
Albuminuria
The presence of microalbuminuria was evaluated in each patient by measuring the albumin-to-creatinine ratio (ACR) on three non-consecutive, first morning urine samples. The ACR was calculated as follows: urine albumin concentration (milligrams per litre)/urine creatinine concentration (mmol per litre) and expressed in mg/mmol. Urine albumin concentration was measured by a commercially available radio-immunoassay kit (Sclavo, Cinisello Balsamo, Italy). The intra-and inter-assay coefficients of variation of ACR in our laboratory were 4.5% and 6.1% respectively. The average (arithmetic mean) of the three ACRs from each patient was calculated in order to categorise patients. In order to account for differences in basal creatinine excretion rates and BMI, different values were used to define microalbuminuria in males (ACR between 2.38 and 19) and in females (ACR between 2.96 and 20) respectively. These criteria proved to have good sensitivity and specificity in detecting albumin excretion rates between 20 and 200 g/min.
10,11
Electrocardiography
Standard ECGs were evaluated to detect LVH. LVH was defined by the presence of at least one of two electrocardiographic criteria: the Sokolow-Lyon voltage and the gender-specific Cornell voltage.
12,13
Echocardiography
All echocardiographic studies were performed using an Acuson XP-128 ultrasound machine. Echocardiograms were obtained at rest with patients supine in the left lateral position, using standard parasternal and apical views. The overall monodimensional left ventricular measurements and the bidimensional (apical four-and two-chamber) views were obtained according to the recommendations of the American Society of Echocardiography. All tracings were obtained and read by a single observer blinded to the clinical characteristics of the patients under observation. LV mass was derived using the formula described by Devereux and associates: 14, 15 LV mass (grams) = 0. ). The presence of LVH was defined for LVMI Ͼ51 g/m 2.7 in either gender.
16-17
Carotid ultrasonography
The intima plus media thickness (IMT) of both carotid arteries was evaluated by high resolution US scan as described by Kawagishi 18 using a 10-MHz in-line duplex Diasonic Spectra System. The carotid artery was scanned at the bifurcation and at the common carotid artery (CCA). At each longitudinal projection the far-wall IMT, as defined by Weldelhag, 19 was measured at the distal end of the CCA, 10 mm caudally to the point where the near and far walls lose their parallel configuration. Carotid plaque was defined as IMT Ͼ1.3 mm. IMT was always measured on the CCA outside the plaque, if any was present. Each measurement was calculated using the average of three readings.
Statistical analysis
All data are expressed as mean ± s.e.m. Comparison of proportion between groups was performed using the 2 test. Variables found to deviate from normality were log-transformed (log 10 ) before statistical analysis. The Pearson correlation test was used to study the linear relationship between ACR and other continuous variables.
Multivariate (k-mean cluster) analysis was performed on the entire cohort of patients to identify subgroups (clusters) of patients on the basis of the severity of target organ damage (ie, IMT and LVMI values) and urine albumin excretion (ACR). The aim of the k-mean clustering procedure is to classify patients in clusters with the lowest within-group variability and the highest among group variability for any given set of variables. Patients within the same cluster show similar values for the variables taken into consideration, while differing from patients in the other clusters for those same variables. The algorithm starts with k random clusters, and then moves cases in and out of clusters in an attempt to (a) minimise variability within clusters and (b) maximise variability among clusters. This is analogous to 'ANOVA in reverse' in the sense that the significance test in ANOVA measures the among group variability against the within-group variability when computing the significance test for the hypothesis that the means in the groups are different from each other. To evaluate the appropriateness of classiJournal of Human Hypertension fication, the within-cluster variability (low if the classification is good) is compared to the betweencluster variability (high if the classification is good), ie, a standard among-group analysis of variance for each variable is performed. 20 Cluster analysis, applied to our study sample of 346 patients, allowed us to detect a difference of 0.8 mg/mmol in ACR, 3.5 g/m 2.7 in LVMI, and 0.01 mm in IMT respectively, with the two-sided significance test at a 1% level and a ␤ probability of 0.1.
All statistical analyses were performed using Statview for Windows, SAS Institute Inc, version 5.0.1, Cary, NC, USA. A P value of Ͻ0.05 was considered statistically significant.
Results
Study population
Clinical characteristics of the study patients are reported in Table 1 . The overall prevalences of microalbuminuria, LVH, and carotid plaque were 13, 51, and 24% respectively. Seventy-five patients (22%) had electrocardiographic signs of LVH (according to one of the two study criteria). Overall, ECGs were available for 339 out of 346 patients. ACR was significantly correlated with blood pressure, BMI, serum lipids, as well as the severity of endorgan damage, namely LVMI and carotid IMT ( Table 2) .
To further investigate the relationship between albuminuria and TOD, k-mean cluster analysis was applied to data from the entire study population. Three subgroups of patients were identified (cluster no 1, n = 58, cluster no 2, n = 129 and cluster no 3, n = 123), differing significantly from each other by Data are mean ± s.d., except for duration of hypertension, triglycerides and ACR mean reported as median (range). HDL = highdensity lipoprotein; ACR = urinary albumin to creatinine ratio; IMT = intimamedia thickness; LVMI = left ventricular mass index; LVH = left ventricular hypertrophy. the severity of target organ damage (ie, carotid IMT and LVMI) as well as by ACR (P Ͻ 0.0001 for each of the variables examined by multimethod, between group ANOVA, and contrast analysis) ( Figure 1 and Table 3 ). There was no difference regarding the percentage of active smokers in the three subgroups of patients. Patients with more severe involvement of end organs had a higher prevalence of ECG-detected LVH (25 vs 13%, OR 4.59 P = 0.03), higher blood pressure (P Ͻ 0.01) and worse lipid profiles (P Ͻ 0.03). Moreover, the subgroup of patients with TOD also showed higher BMI (P = 0.04), age (P = 0.03), and BP levels (P = 0.01) as compared with the subgroup without TOD (data not shown). Furthermore, patients with Mi were more likely to have both LVH and thicker IMT (above the median) (OR 21, 95% CI 4.6-99.97, P Ͻ 0.0001) (Figure 2 ). Mi showed 96% specificity and 45% sensitivity for detecting LVH or the concomitant presence of LVH and increased IMT. These values led to 88% and 90% positive predictive power (PPP) and 59% and 69% negative pre- Among the entire study population, three subgroups of patients were identified (cluster no 1, no 2, and no 3), differing significantly from each other by the presence and severity of several features of target organ damage (ie, carotid IMT and LVMI) as well as by urinary albumin excretion (ACR) (P Ͻ 0.001 for each of the variables examined by multimethod, between group ANOVA, and contrast analysis). Degrees of freedom 1-307. ACR = albumin to creatinine ratio, mg/nmol; IMT = intima plus media thickness, mm; LVMI = left ventricular mass index, g/m 2, 7 . dictive power for the presence of LVH or both TOD respectively.
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Discussion
The present study shows that Mi is a marker of subclinical end-organ damage, ie LVH and peripheral atherosclerosis. In fact, UAE was strongly correlated with LVMI and carotid IMT in our study population of non-diabetic hypertensive patients (Table 2) . By using cluster analysis we were able to demonstrate in a new and original way that different types of TOD tend to aggregate with increased UAE in the same subgroup of patients ( Figure 1 ) and therefore, that Mi is an excellent integrated marker of high risk cardiovascular status. The three subgroups of patients identified by cluster analysis differ significantly as for the presence and degree of TOD, as well as for UAE, while patients within the same cluster show similar values as indicated by ANOVA (Table 3). Thus, it appears that patients with higher LVMI and IMT (ie those in cluster no 1) also have higher UAE values. Moreover, the clustering of UAE with higher values of LVMI and IMT is in agreement with previous reports by our group and by others, 10, [21] [22] [23] and indicate an association among microalbuminuria, LVH and carotid atherosclerosis. Therefore, measuring urinary ACR, a simple, low cost and readily available test, can be regarded as a cost-effective way to identify, among the large number of hypertensive patients, those who need additional preventive measures and/or more aggressive antihypertensive treatment. In fact, when the degree of subclinical organ damage is observed on the basis of UAE (Figure 2 ), it appears that patients with Mi are more likely to have both LVH and higher carotid IMT (P Ͻ 0.0001). The probability that a patient with increased UAE also shows these two signs of TOD is 21 times higher as compared with patients with normal urine albumin excretion (PPP 88% for LVH and 90% for both LVH and increased IMT). Thus, the high specificity of Mi for identifying TOD makes it an attractive screening test for all hypertensive patients. The pathogenetic mechanisms underlying increased UAE in non-diabetic hypertensive patients are not fully understood. The severity of blood pressure load and the increased systemic permeability to albumin, possibly due to early endothelial dysfunction, seem to play a major role in the development of this abnormality. 24 Several data, however, suggest an interplay among additional factors/mechanisms such as abnormalities in the lipid metabolism, 25, 26 prothrombotic factors, 3, 27 and increased activity of the renin-angiotensin system. 28 Finally, a functional haemodynamic abnormality (ie an increased filtration fraction due to higher angiotJournal of Human Hypertension ensin II levels) and/or the presence of structural changes within the kidney cannot be ruled out as causes of Mi in essential hypertension, at least until these issues have been addressed by properly devised studies, and the renal prognostic value of mild increases in UAE established. Our data show significant linear correlations between UAE and blood pressure, BMI, and serum lipids. These findings, together with the clustering of hypertensive TOD and differences among clusters as for several known biochemical and clinical risk factors, suggest multifactorial pathogenesis although they do not prove it.
In conclusion the present study confirms and extends previous work on the role of Mi as an integrated marker of increased cardiovascular risk in essential hypertension. On the basis of these results we propose searching for Mi as part of the initial work-up of every hypertensive patient.
